registered   |   log in
  中文
Nanomedicine
position: home > Nanomedicine > Nanomedicine—Orthopedics

IF15! | The core mechanism of TSP1/2 in regulating bone ectopicization

source:material synthesis Views:129time:2026-04-01material synthesis: 1092348845

已传文件:photo/1773121782.png This study focuses on the key regulatory factors of extracellular matrix (ECM) and mesenchymal precursor cells (MPCs), with the core research scenario being trauma-induced ectopic bone formation (HO). It aims to explore the regulatory functions of maternal thromboxane 1 (TSP1) and thromboxane 2 (TSP2). Through single-cell RNA sequencing, spatial transcriptomics, and in vivo models, the differential distribution characteristics of TSP1 and TSP2 at the injury site were clarified. It was confirmed that the double knockout of TSP1 and TSP2 could disrupt the arrangement of ECM and inhibit the formation of HO. This study first established TSP1/2 as the core regulatory factors for the interaction between MPCs and ECM, elucidating their key roles in muscle and bone tissue injury repair and the progression of HO formation, providing a new theoretical basis for the mechanism research of bone-related pathological processes.
This review addresses the regeneration and repair challenges caused by the heterogeneity of bone-cartilage tissue, with the tissue engineering system combining mesenchymal stem cells and biomaterial scaffolds as the core. It clarifies the regulatory mechanism of biological physical signals on the fate of stem cells, systematically summarizes the progress in the design of biomimetic microenvironment scaffolds under the guidance of mechanical biology, achieving precise regulation of the lineage-specific differentiation of mesenchymal stem cells, and providing theoretical support and design references for layered bone-cartilage regeneration, especially the regeneration of subchondral bone.
01 Research Background
TSP1 and TSP2, as key regulatory factors of ECM interaction, participate in the process of cell differentiation and tissue repair. Existing studies have confirmed that abnormal ECM arrangement can lead to abnormal differentiation of MPCs and subsequently induce ectopic bone formation, which is the core cause of trauma-induced ectopic bone formation (HO). However, the key regulatory molecules for the interaction between MPCs and ECM have not yet been clearly identified, which limits the in-depth analysis of the mechanisms of bone tissue injury repair and HO formation, and also poses constraints on the advancement of research in bone-related pathologies.
The tendon-bone transitional tissue has a highly specialized extracellular matrix structure, with the core feature being the hierarchical arrangement of collagen and the gradient composition of minerals. This structural system can achieve stable force transmission and guide the cell phenotype of the spatial organization. Currently, it is impossible to precisely reproduce the complex multi-scale structure and composition gradient at the tendon-bone interface, which has become a key bottleneck hindering the integration and regeneration of soft and hard tissues. There is an urgent need to develop biomimetic matrix construction schemes that conform to the characteristics of natural structures.
02 Main Content
This study focuses on bone tissue trauma repair and HO occurrence as the core scenario, and conducts systematic research on maternal TSP1 and TSP2. The core objective is to clarify the regulatory roles of TSP1 and TSP2 in the interaction between MPCs and ECM, and to analyze their distribution characteristics and the mechanisms of their influence on ECM arrangement and HO formation, filling the research gap in the key regulatory factors of MPCs and ECM interaction.
03 Research Design
1. Technical means: Integrating three core technical means - single-cell RNA sequencing, spatial transcriptomics, and in vivo mouse model experiments - to achieve precise molecular-level analysis and in vivo functional validation.
2. Experimental model: Constructing a TSP1/2 double knockout (DKO) mouse model, with wild-type mice as the control, to conduct in vivo functional validation experiments.
3. Research subjects: Focusing on tissue remodeling macrophages at the injury site, mesenchymal precursor cells (MPCs), and MPCs surrounded by HO anti-adhesive substances, to clarify the distribution and functional association of TSP1/2. 04
Result
1. Distribution characteristics of TSP1: In the tissue remodeling macrophages and mesenchymal precursor cells (MPCs) at the trauma site, TSP1 shows a significant upregulation trend.
2. Distribution characteristics of TSP2: The expression of TSP2 is specific, being only located in the MPCs surrounded by HO adhesion proteins. It shows no significant expression in other injury-related cells.
3. Phenotype of knockout model: The ECM arrangement in TSP1/2 double knockout (DKO) mice is significantly disordered, and the process of ectopic ossification (HO) induced by trauma is significantly inhibited.
4. Core conclusion: TSP1 and TSP2 are key regulatory factors mediating the interaction between MPCs and ECM. They jointly participate in the process of muscle and bone injury repair and play a core regulatory role in the formation and progression of HO.

5. Extension of ideas
1. Deeply analyze the molecular pathways regulated by TSP1/2 in determining MPC fate and ECM remodeling, clarify the upstream and downstream regulatory molecules and signal transduction mechanisms.
2. Expand the research on the regulatory mechanisms of TSP1/2 in different bone injury types (such as fractures, bone defects, post-traumatic bone deformities), verify their universal regulatory functions in bone tissue injury repair.
3. Explore the synergistic or antagonistic effects of TSP1/2 with bone tissue-related regulatory factors (such as bone morphogenetic proteins, transcription factors, etc.), construct a regulatory network for bone tissue injury repair.
4. Analyze the physiological functions of TSP1/2 in maintaining bone tissue homeostasis, clarify their regulatory roles in the normal bone metabolism process, and expand the boundaries of basic research in the field of bone.


 

Reminder: Beijing Beike New Material Technology Co., Ltd. supplies products only for scientific research, not for humans
All rights reserved © 2019 beijing beike new material Technology Co., Ltd 京ICP备16054715-2号
advisory
phone
Email:mxenes@163.com
Tel:+86-17715390137
scan

scan
WeChat